Correspondence 0001477932-25-004196 from MED-X, INC. (CIK 0001620704)

MED-X, INC. (CIK 0001620704)
Date: May 27, 2025 · CIK: 0001620704 · Accession: 0001477932-25-004196

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-12516

Date

May 29, 2025

Author

Not clearly detected

Form

CORRESP

Company

MED-X, INC. (CIK 0001620704)

Letter

Re:

medx_corresp.htmMay 27, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Med-X, Inc.

Offering Statement on Form 1-A

File No. 024-12516

Ladies and Gentlemen:

In accordance with Rule 252(e) under the Securities Act of 1933, as amended, the undersigned respectfully requests that the qualification date for the above-referenced Offering Statement be accelerated so that it will be declared qualified at 4:00 p.m. Eastern Time on May 29, 2025, or as soon thereafter as is practicable.

Please contact Jesse L. Blue, Esq. with Sichenzia Ross Ference Carmel LLP (516) 668-4553 once the Offering Statement is declared qualified.

MED-X, INC.

By: /s/ Matthew Mills

Matthew Mills

Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

medx_corresp.htmMay 27, 2025

 VIA EDGAR

 Securities and Exchange Commission

 Division of Corporation Finance

 100 F. Street, N.E.

 Washington, D.C. 20549

   Re:

   Med-X, Inc.

   Offering Statement on Form 1-A

   File No. 024-12516

 Ladies and Gentlemen:

 In accordance with Rule 252(e) under the Securities Act of 1933, as amended, the undersigned respectfully requests that the qualification date for the above-referenced Offering Statement be accelerated so that it will be declared qualified at 4:00 p.m. Eastern Time on May 29, 2025, or as soon thereafter as is practicable.

 Please contact Jesse L. Blue, Esq. with Sichenzia Ross Ference Carmel LLP (516) 668-4553 once the Offering Statement is declared qualified.

        MED-X, INC.

    By:   /s/ Matthew Mills

  Matthew Mills

         Chief Executive Officer

SecProbe.io